Galderma Group AG (GDERF)
220.35
-3.65
(-1.63%)
USD |
OTCM |
Nov 13, 16:00
Galderma Group Price : 220.35 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 238.65 | 238.65 | 220.35 | 220.35 | 922.00 |
| Nov 12, 2026 | 232.68 | 232.68 | 224.00 | 224.00 | 1965.00 |
| Nov 11, 2026 | 224.90 | 224.90 | 224.90 | 224.90 | 1561.00 |
| Nov 10, 2026 | 225.65 | 225.65 | 224.90 | 224.90 | 523.00 |
| Nov 09, 2026 | 233.55 | 234.30 | 228.30 | 228.30 | 29.00 |
| Nov 06, 2026 | 231.09 | 231.09 | 231.09 | 231.09 | 0.000 |
| Nov 05, 2026 | 240.00 | 240.00 | 231.09 | 231.09 | 102.00 |
| Nov 04, 2026 | 230.00 | 230.00 | 230.00 | 230.00 | 157.00 |
| Nov 03, 2026 | 224.22 | 239.25 | 224.22 | 229.07 | 18.00 |
| Nov 02, 2026 | 239.25 | 239.25 | 228.00 | 229.00 | 692.00 |
| Oct 30, 2026 | 239.25 | 239.25 | 225.82 | 226.67 | 35.00 |
| Oct 29, 2026 | 237.20 | 237.20 | 222.26 | 226.00 | 13022.00 |
| Oct 28, 2026 | 232.55 | 232.55 | 214.45 | 214.45 | 161.00 |
| Oct 27, 2026 | 232.95 | 232.95 | 218.62 | 218.66 | 84.00 |
| Oct 26, 2026 | 239.95 | 239.95 | 239.95 | 239.95 | 137.00 |
| Oct 23, 2026 | 238.75 | 238.75 | 230.86 | 230.86 | 77.00 |
| Oct 22, 2026 | 228.70 | 230.00 | 217.69 | 220.14 | 12035.00 |
| Oct 21, 2026 | 215.30 | 220.95 | 211.48 | 220.95 | 60.00 |
| Oct 20, 2026 | 221.45 | 221.45 | 205.79 | 211.86 | 11.00 |
| Oct 19, 2026 | 220.31 | 220.31 | 220.25 | 220.25 | 217.00 |
| Oct 16, 2026 | 213.94 | 221.30 | 204.50 | 220.55 | 108.00 |
| Oct 15, 2026 | 215.95 | 216.70 | 201.78 | 216.70 | 66.00 |
| Oct 14, 2026 | 197.59 | 213.40 | 197.59 | 197.80 | 107.00 |
| Oct 13, 2026 | 202.06 | 202.06 | 193.82 | 193.82 | 1222.00 |
| Oct 12, 2026 | 203.16 | 210.90 | 203.16 | 210.90 | 4.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 160.50 |
| Roche Holding AG | 60.30 |
| Addex Therapeutics Ltd. | 4.06 |
| Oculis Holding AG | 7.64 |
| Sandoz Group AG | 100.76 |
Price Related Metrics
| PE Ratio | 60.18 |
| PS Ratio | 8.814 |
| Price to Free Cash Flow | 48.96 |
| Earnings Yield | 1.66% |
| Market Cap | 51.38B |
| Operating PE Ratio | 47.57 |
| Normalized PE Ratio | 56.18 |